Physician profile
Michael C Carozza
NPI 1093772055
$1,976.67
in general payments reported to CMS, 2019-2025
25 companies · $338 in 2025
The $338 reported for 2025 was more than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $65.24 · 2020: $71.15 · 2021: $613 · 2022: $358 · 2023: $373 · 2024: $158 · 2025: $338.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $869.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $869.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $414.62 | 2019-2025 | |
| Abbvie INC. | $161.71 | 2020-2021 | |
| Medtronic, INC. | $156.63 | 2021-2025 | Interstim, Truclear |
| Organon LLC | $149.39 | 2022-2025 | Nexplanon |
| Daiichi Sankyo INC. | $132.79 | 2021 | |
| Dexcom, INC. | $110.60 | 2024-2025 | Dexcom G6 Transmitter |
| Baxter Healthcare | $98.94 | 2023 | Perclot |
| Alexion Pharmaceuticals, INC. | $83.57 | 2021 | |
| Sumitomo Pharma America, INC. | $74.38 | 2023-2025 | Myfembree, Gemtesa |
| Vertex Pharmaceuticals Incorporated | $71.83 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $66.19 | 2019-2025 | |
| Minerva Surgical, INC | $64.10 | 2020-2025 | |
| Gynesonics, INC. | $61.86 | 2022 | |
| Novo Nordisk INC | $61.20 | 2019-2021 | |
| Agile Therapeutics, INC. | $51.29 | 2023-2024 | Twirla |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $48.91 | 2022-2025 | Cook, Paragard T 380a |
| Hologic Sales and Service, LLC | $34.79 | 2021-2025 | Thinprep 2000 Processor, Aptima |
| Merck Sharp & Dohme LLC | $29.47 | 2019-2021 | |
| Scynexis, INC. | $19.95 | 2022 | |
| Ethicon US, LLC | $19.00 | 2021 | |
| Therapeuticsmd, INC. | $17.53 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $15.58 | 2023 | Exparel |
| Exeltis, USA INC. | $14.63 | 2025 | Slynd |
| Exact Sciences Corporation | $13.98 | 2023 | Cologuard Collection Kit |
| Kinex Medical Company LLC | $3.73 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Carozza listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.